产后致死性肺栓塞合并F5基因突变一例
报道一例25岁女性剖宫产后1天突发心跳呼吸骤停,诊断为下肢深静脉血栓形成合并肺栓塞,经心肺复苏、阿替普酶溶栓及VA-ECMO支持后好转出院。实验室检查抗心磷脂IgM抗体阳性,全外显子测序检出F5基因c.2032A>G(p.Lys678Glu)杂合错义突变,提示需关注年轻肺栓塞患者的病因筛查。
要点
- 剖宫产、超重、抗心磷脂抗体阳性及F5基因突变可共同促发产后肺栓塞。
- VA-ECMO可用于产后肺栓塞溶栓后血流动力学不稳定者的循环支持。
- 年轻肺栓塞患者应进行病因筛查,以指导抗凝方案与疗程。
核心结论
- 年轻肺栓塞患者应重视病因筛查,有助于指导抗凝方案和疗程,对预防血栓复发和并发症有重要意义。
研究设计与样本
- 个案报道:1例25岁女性剖宫产后1天发生心跳呼吸骤停,诊断为下肢深静脉血栓形成合并肺栓塞。
主要发现
- 患者经心肺复苏、阿替普酶溶栓、VA-ECMO体外循环和抗凝等治疗后症状好转出院。
- 抗心磷脂IgM抗体为73.86 MPL,3个月后复查为22.92 MPL。
- 全外显子测序检出F5/NM_000130.4基因c.2032A>G(p.Lys678Glu)杂合错义突变。
- 该突变预测导致第678位赖氨酸替换为谷氨酸,靠近一个APC切割位点。
- SIFT软件预测p.Lys678Glu为有害突变,Polyphen-2软件预测为疑似有害。
临床怎么用
- 对年轻肺栓塞患者应进行包括易栓症相关基因和抗磷脂抗体在内的病因筛查。
- 产后肺栓塞患者经溶栓后血流动力学仍不稳定时,可考虑VA-ECMO支持。
- 病因筛查结果有助于个体化制定抗凝方案和抗凝持续时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary embolism (PE) is one of the leading causes of maternal death. Various clinical and environmental risk factors can cause PE. Here, we reported an uncommon PE case with multiple etiological causes, including caesarean section, overweight, anti-cardiolipin antibody positive, and factor 5 gene mutation. The patient was a 25-year-old woman who developed cardiac asystole and apnea one day after cesarean delivery due to pulmonary embolism. After cardiopulmonary resuscitation and thrombolytic therapy, high doses of epinephrine were still needed to maintain blood pressure and heart rate, so we treated her with venoarterial extracorporeal membrane oxygenation (ECMO) to maintain systemic circulation. She progressively improved and was discharged on oral warfarin treatment. Comprehensive laboratory tests revealed a positive anticardiolipin antibody. Through whole exon gene sequencing, we identified a novel mutation (A2032➝G) in the F5 gene. This mutation was predicted to result in the replacement of lysine with glutamate at position 678, close to one of the APC cleavage sites. P.Lys678Glu was found to be a detrimental mutation by SIFT software and suspected detrimental by Polyphen-2 software. Attention should be paid to the etiological screening of young patients with pulmonary embolism, which is helpful in guiding the anticoagulant scheme and anticoagulant duration, and is of great significance in preventing thrombosis recurrence and complications. 患者女,25岁,剖宫产后1 d突发心跳呼吸骤停,诊断为下肢深静脉血栓形成合并肺栓塞。经心肺复苏、阿替普酶溶栓,建立体外膜氧合(ECMO)体外循环和抗凝等治疗后,症状好转出院。住院期间完善肿瘤标志物无明显异常,抗核抗体谱、抗中性粒细胞胞质抗体、抗肾小球基底膜抗体均无明显异常,抗心磷脂 IgM 抗体为73.86 MPL,3个月后复查抗心磷脂IgM 抗体22.92 MPL,采用全外显子基因测序检出F5/NM_000130.4基因c.2032A>G(p.Lys678Glu)杂合错义突变。.
引用
- Zhang, Kong, Chen, et al. [Postpartum fatal pulmonary embolism with F5 gene mutation: a case report]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37402662. doi:10.3760/cma.j.cn112147-20230417-00181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。